European Cancer Congress - 2026

 Welcome to the European Cancer Congress – 2026

Arjyopa Healthcare warmly welcomes you to attend the European Cancer Congress – 2026, scheduled for 23rd–24th November, 2026, in London, England. This year’s Congress is organized around the powerful theme: "TOGETHER AGAINST CANCER: SCIENCE, SOLIDARITY, AND SOLUTIONS".

We cordially invite all participants who are passionate about sharing their knowledge and advancing research in the fields of Oncology and Cancer Research.

We are also pleased to share that the European Cancer Congress is a subsidiary of the World Cancer Congress series by Arjyopa, further expanding our mission to foster knowledge exchange and collaboration among cancer researchers, clinicians, and healthcare leaders worldwide. In 2026, we are excited to recreate that vibrant, inspiring environment while bringing new dimensions to the discussion — including the integration of complementary approaches in cancer treatment.

Cancer in England: Urgent Realities

In 2023-2025, the UK is projected to see around 420,000 new cancer cases diagnosed each year. This number is projected to rise to around 506,000 cases by 2038-2040. Between 2023-2025 and 2038-2040, the overall incidence rate for all cancers combined is projected to increase by 2%, reaching 625 cases per 100,000 people annually. Specific to females, the increase is projected to be 1%, and for males, it's projected to be 3%.

In 2022, 288,753 new cancer cases were diagnosed in England. The incidence rate was 21% higher in men than in women. More than half of these cases were diagnosed in people over the age of 70. Among adults aged 25 to 59, cancer was more commonly diagnosed in women, while for those aged 65 and older, incidence was approximately 50% higher in men.

Four types of cancer—prostate, breast, lung, and colorectal—accounted for over half of all diagnoses. Cancer remains a leading cause of death, responsible for over a quarter of all annual deaths in England, with 134,802 cancer-related deaths reported in 2021 alone.

A Global Call to Strengthen, Inspire, and Deliver

We expect to welcome thousands of cancer researchers, healthcare professionals, policy-makers, and industry experts from around the globe to London this November. Together, we will explore new frontiers in science, foster solidarity among the international cancer community, and develop actionable solutions to reduce the burden of cancer worldwide.

Scientific Focus Areas

The Congress will feature a diverse and comprehensive scientific program covering key areas such as:

Cancer Biology and Genetics

Organ-Defined Cancers

Oncology Sub-specialties

Radiation and Surgical Oncology

Stem Cell Therapy and Precision Medicine

Cancer Epidemiology, Prevention, and Pharmacology

Cancer Immunology, Vaccines, and Immunotherapy

Oncology Nursing and Palliative Care

Complementary and Alternative Medicine

Lifestyle, Nutrition, and Cancer Survivorship

Psychological and Social Aspects of Cancer

Join us alongside leading oncologists, scientists, clinicians, pharmaceutical innovators, university researchers, diagnostic experts, and healthcare professionals from every corner of the world.

We look forward to welcoming you to London in November 2026. Together, let’s stand united against cancer—through science, solidarity, and solutions.